A case of invasive aspergillosis A case of invasive aspergillosis
in a lung transplant patientin a lung transplant patient
Dr. Dino SgarabottoDr. Dino Sgarabotto
Transplant ID UnitTransplant ID Unit
Padova General HospitalPadova General Hospital
ItalyItaly
Cystic fibrosis
Pancreatic insufficiency
Insulin-dependent diabetes mellitus
Bilateral lung transplant (2008)
>> cyclosporine and steroids
Hypertension
Mild renal impairment
AC, 35 years oldAC, 35 years old
20092009:
Invasive aspergillosis involving:
brain, lung and mitral valve,
Treated with
Caspofungin and Voriconazole for 60 days
Voriconazole 200 mg bid for 16 months
No surgery
Sensitivity testing not done
Clinical HistoryClinical History
[>> Urine culture grew Aspergillus sp.,
so he received a longer treatment with caspofungin]
September 2010September 2010:
Pneumocystis carinii pneumonia: ICU admission
The patient suffered from fever and urine retention.
Treated unsuccessfully with ciprofloxacin.
Persistence of 39°C intermittent fever every 3 days:
new hospitalization
December 2010December 2010
Blood and urine culture: negativeBlood and urine culture: negative
WBC: normal; anemiaWBC: normal; anemia
CRP: 128 mg/dLCRP: 128 mg/dL
PSA: normalPSA: normal
Creatinine: 132 mmol/LCreatinine: 132 mmol/L
Chest X-Ray: negativeChest X-Ray: negative
December 2010December 2010
Transrectal US: small prostatic abscesssmall prostatic abscess
Cultures from post-prostatic massage fluid:
Aspergillus sppAspergillus spp..
Abdomen US: 4.5 cm mass on the left upper kidney4.5 cm mass on the left upper kidney
Chest CT scan, echocardiography and cerebral MRI : Chest CT scan, echocardiography and cerebral MRI :
unremarkable. unremarkable.
The patient was restarted on voriconazole/caspofungin
3 weeks later
fever unchanged, CRP 110 mg/dL and
voriconazole trough level 3.2 ug/dL
Patient treatment hystoryPatient treatment hystory
Therapy was switched to Liposomal Amphotericin B 3mg/
Kg/daily
quick (1 day) disappearance of fever,
CRP normalization,
new culture of post-prostatic massage fluid: negative
Clinical case: March 2011… no fever, but…Clinical case: March 2011… no fever, but…
0
50
100
150
200
250
300
350
days
creatinine mmol/L
surgical
enucleation
Follow up: May-July 2011Follow up: May-July 2011
US scan: no recrudescenceUS scan: no recrudescence No feverNo fever
…but..
100
150
200
250
300
350
05 /05 /2 011
09 -m ag 12 -m ag 16 -m ag 19 -m ag 23 -m ag 26 -m ag 30 -m ag
02 -gi u 06 -gi u 09 -gi u 13 -gi u 16 -gi u 20 -gi u 23 -gi u 30 -gi u
creatinine mg/dL
0
10
20
30
40
50
60
CRP mg/dL
STOPSTOP
LAmb 3 mg/kg/dieLAmb 3 mg/kg/die
Lung transplant recipients are at high risk
of invasive Aspergillosis.
However, isolated urinary involvement of invasive
aspergillosis is uncommon and its treatment is very
controversial.
Conclusions (1)Conclusions (1)
• We observed the development of microbiological
resistance to Voriconazole and pharmacokinetic/clinical
inefficacy of Caspofungin.
•Voriconazole-resistant Aspergillus is a new problem
• Efficacy of LAmB…
…but hard management because nefrotoxicity and
concomitant use of Cyclosporine
Conclusions (2)Conclusions (2)
• In invasive aspergillosis: LAmB effectiveness only if
combined to surgery?
• Is there a genetic predisposition for invasive
aspergillosis or are there other still unknown risk
factors?
• How can we manage antifungal secondary
prophylaxis in this patient?
• Secondary prophylaxis with iv Ambisome is not yet
defined:
•3 mg/kg/daily 2 weeks a month?
•5 mk/Kg twice a week?
•10 mg/Kg/weekly? How long???
Further questions Further questions